Area of research
Infectious Diseases · Immunology
Research interest
Research interests include Immune Cell Function and Interaction, HIV Research and Treatment, COVID-19 Clinical Research Studies, and SARS-CoV-2 and COVID-19 Research.
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infection.
Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial
Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights.
Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1.
Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial.
A human skin microbiome reference catalog and the skin microbial landscape of plateau adults
GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV.
Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B.
Dysfunction and Metabolic Reprogramming of Gut Regulatory T Cells in HIV-Infected Immunological Non-Responders.
CD300A<sup>+</sup> CD8<sup>+</sup> T Cells as Predictive Biomarkers for Achieving Functional Cure in Chronic Hepatitis B Patients Undergoing Pegylated Interferon-Alpha Therapy.
A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure.
Safety and efficacy of human umbilical cord-derived mesenchymal stem cells in COVID-19 patients: A real-world observation.
Relationship between postablation fever and prognosis in initial hepatocellular carcinoma: a 15-year multicenter, retrospective cohort study.
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B.
Targeting exosomal double-stranded RNA-TLR3 signaling pathway attenuates morphine tolerance and hyperalgesia
Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19.
Landscape of gut mucosal immune cells showed gap of follicular or memory B cells into plasma cells in immunological non-responders.
Integrated transcriptomic analysis reveals dysregulated immune infiltration and pro-inflammatory cytokines in the secretory endometrium of recurrent implantation failure patients
HBeAg induces neutrophils activation impairing NK cells function in patients with chronic hepatitis B.
Treatment of Paraclinoid Aneurysms With Stent-Assisted Coiling Versus Flow Diversion Techniques: A Systematic Review and Meta-Analysis
Implications of accumulation of clonally expanded and senescent CD4<sup>+</sup>GNLY<sup>+</sup> T cells in immunological non-responders of HIV-1 infection.
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreak.
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a study.
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients.
Intra-arterial tenecteplase following endovascular therapy in patients with acute posterior circulation arterial occlusion: study protocol and rationale
Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection.
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
The mediating effect of psychological resilience between social support and anxiety/depression in people living with HIV/AIDS-a study from China.